Skin resurfacing procedures: new and emerging options

Mathew M Loesch, Ally-Khan Somani, Melanie M Kingsley, Jeffrey B Travers, Dan F Spandau, Mathew M Loesch, Ally-Khan Somani, Melanie M Kingsley, Jeffrey B Travers, Dan F Spandau

Abstract

The demand for skin resurfacing and rejuvenating procedures has progressively increased in the last decade and has sparked several advances within the skin resurfacing field that promote faster healing while minimizing downtime and side effects for patients. Several technological and procedural skin resurfacing developments are being integrated into clinical practices today allowing clinicians to treat a broader range of patients' skin types and pathologies than in years past, with noteworthy outcomes. This article will discuss some emerging and developing resurfacing therapies and treatments that are present today and soon to be available.

Keywords: non-melanoma skin cancer; rejuvenation; therapy; wounding.

References

    1. ASDS [homepage on the Internet] ASDS survey: Skin cancer, cosmetic procedures jump 22 percent in 2013. 2014. [Accessed February 10, 2014]. Available from: .
    1. Lipozencic J, Bukvic Mokos Z. Dermatologic lasers in the treatment of aging skin. Acta Dermatovenerol Croat. 2010;18(3):176–180.
    1. Alster TS, Lupton JR. Lasers in dermatology. An overview of types and indications. Am J Clin Dermatol. 2001;2(5):291–303.
    1. Airan LE, Hruza G. Current lasers in skin resurfacing. Facial Plast Surg Clin North Am. 2005;13(1):127–139.
    1. Tanzi EL, Lupton JR, Alster TS. Lasers in dermatology: four decades of progress. J Am Acad Dermatol. 2003;49(1):1–31.
    1. Smith KC, Schachter GD. YSGG 2790-nm Superficial Ablative and Fractional Ablative Laser Treatment. Facial Plast Surg Clin North Am. 2011;19(2):253–260.
    1. Stulhofer Buzina D, Lipozencic J, Bukvic Mokos Z, Ceovic R, Kostovic K. Ablative laser resurfacing: is it still the gold standard for facial rejuvenation? Acta dermatovenerol Croat. 2010;18(3):190–194.
    1. Alexiades-Armenakas MR, Dover JS, Arndt KA. Fractional laser skin resurfacing. J Drugs Dermatol. 2012;11(11):1274–1287.
    1. Saedi N, Jalian HR, Petelin A, Zachary C. Fractionation: past, present, future. Semin Cutan Med Surg. 2012;31(2):105–109.
    1. Saedi N, Petelin A, Zachary C. Fractionation: a new era in laser resurfacing. Clin Plast Surg. 2011;38(3):449–461.
    1. Bloom BS, Brauer JA, Geronemus RG. Ablative fractional resurfacing in topical drug delivery: an update and outlook. Dermatol Surg. 2013;39(6):839–848.
    1. Hædersdal M, Sakamoto FH, Farinelli WA, Doukas AG, Tam J, Anderson RR. Fractional CO2 laser-assisted drug delivery. Lasers Surg Med. 2010;42(2):113–122.
    1. Prasanthi D, Lakshmi PK. Vesicles – mechanism of transdermal permeation: a review. Asian Journal of Pharmaceutical and Clinical Research. 2012;5(1):18–25.
    1. Haak CS, Farinelli WA, Tam J, Doukas AG, Anderson RR, Haedersdal M. Fractional laser-assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incubation time. Lasers Surg Med. 2012;44(10):787–795.
    1. Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, Haedersdal M. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol. 2012;166(6):1262–1269.
    1. Lee WR, Shen SC, Wang KH, Hu CH, Fang JY. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J Pharm Sci. 2002;91(7):1613–1626.
    1. Lee WR, Shen SC, Al-Suwayeh SA, Yang HH, Yuan CY, Fang JY. Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules. J Control Release. 2011;153(3):240–248.
    1. Wang KH, Fang JY, Hu CH, Lee WR. Erbium:YAG laser pretreatment accelerates the response of Bowen’s disease treated by topical 5-fluorouracil. Dermatol Surg. 2004;30(3):441–445.
    1. Waibel JS, Wulkan AJ, Shumaker PR. Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med. 2013;45(3):135–140.
    1. Gratieri T, Alberti I, Lapteva M, Kalia YN. Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin. Eur J Pharm Sci. 2013;50(5):609–622.
    1. Lee WR, Shen SC, Zhuo RZ, Wang KC, Fang JY. Enhancement of topical small interfering RNA delivery and expression by low-fluence erbium:YAG laser pretreatment of skin. Hum Gene Ther. 2009;20(6):580–588.
    1. Lee WR, Shen SC, Liu CR, Fang CL, Hu CH, Fang JY. Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study. J Control Release. 2006;115(3):344–353.
    1. Lee WR, Shen SC, Chen WY, Aljuffali IA, Suen SY, Fang JY. Noninvasive delivery of siRNA and plasmid DNA into skin by fractional ablation: Erbium:YAG laser versus CO laser. Eur J Pharm Biopharm. 2014;86(3):315–323.
    1. Lee WR, Shen SC, Fang CL, Zhuo RZ, Fang JY. Topical delivery of methotrexate via skin pretreated with physical enhancement techniques: low-fluence erbium:YAG laser and electroporation. Lasers Surg Med. 2008;40(7):468–476.
    1. Yu J, Kalaria DR, Kalia YN. Erbium:YAG fractional laser ablation for the percutaneous delivery of intact functional therapeutic antibodies. J Control Release. 2011;156(1):53–59.
    1. Ma G, Wu P, Lin X, et al. Fractional Carbon Dioxide Laser-Assisted Drug Delivery of Topical Timolol Solution for the Treatment of Deep Infantile Hemangioma: A Pilot Study. Pediatr Dermatol. 2014;31(3):286–291.
    1. Genina EA, Bashkatov AN, Dolotov LE, et al. Transcutaneous delivery of micro- and nanoparticles with laser microporation. J Biomed Opt. 2013;18(11):111406.
    1. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259–2272.
    1. Marx RE. Platelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP? Implant Dent. 2001;10(4):225–228.
    1. Kim DH, Je YJ, Kim CD, et al. Can Platelet-rich Plasma Be Used for Skin Rejuvenation? Evaluation of Effects of Platelet-rich Plasma on Human Dermal Fibroblast. Ann Dermatol. 2011;23(4):424–431.
    1. Akhundov K, Pietramaggiori G, Waselle L, et al. Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing. Ann Burns Fire Disasters. 2012;25(4):207–213.
    1. Arshdeep, Kumaran MS. Platelet-rich plasma in dermatology: Boon or a bane? Indian J Dermatol Venereol Leprol. 2014;80(1):5–14.
    1. Na JI, Choi JW, Choi HR, et al. Rapid healing and reduced erythema after ablative fractional carbon dioxide laser resurfacing combined with the application of autologous platelet-rich plasma. Dermatol Surg. 2011;37(4):463–468.
    1. Lee JW, Kim BJ, Kim MN, Mun SK. The efficacy of autologous platelet rich plasma combined with ablative carbon dioxide fractional resurfacing for acne scars: a simultaneous split-face trial. Dermatol Surg. 2011;37(7):931–938.
    1. Gawdat HI, Hegazy RA, Fawzy MM, Fathy M. Autologous platelet rich plasma: topical versus intradermal after fractional ablative carbon dioxide laser treatment of atrophic acne scars. Dermatol Surg. 2014;40(2):152–161.
    1. Zhu JT, Xuan M, Zhang YN, et al. The efficacy of autologous platelet-rich plasma combined with erbium fractional laser therapy for facial acne scars or acne. Mol Med Rep. 2013;8(1):233–237.
    1. Reddy BY, Hantash BM. Emerging technologies in aesthetic medicine. Dermatol Clin. 2009;27(4):521–527.
    1. Krueger N, Sadick NS. New-generation radiofrequency technology. Cutis. 2013;91(1):39–46.
    1. Zelickson BD, Kist D, Bernstein E, et al. Histological and ultrastructural evaluation of the effects of a radiofrequency-based nonablative dermal remodeling device: a pilot study. Arch Dermatol. 2004;140(2):204–209.
    1. Tenna S, Cogliandro A, Piombino L, Filoni A, Persichetti P. Combined use of fractional CO2 laser and radiofrequency waves to treat acne scars: a pilot study on 15 patients. J Cosmet Laser Ther. 2012;14(4):166–171.
    1. Hruza G, Taub AF, Collier SL, Mulholland SR. Skin rejuvenation and wrinkle reduction using a fractional radiofrequency system. J Drugs Dermatol. 2009;8(3):259–265.
    1. Mulholland RS, Ahn DH, Kreindel M, Paul M. Fractional Ablative Radio-Frequency Resurfacing in Asian and Caucasian Skin: A Novel Method for Deep Radiofrequency Fractional Skin Rejuvenation. Journal of Cosmetics, Dermatological Sciences and Applications. 2012;2(3):144–150.
    1. Dahan S, Rousseaux I, Cartier H. Multisource radiofrequency for fractional skin resurfacing-significant reduction of wrinkles. J Cosmet Laser Ther. 2013;15(2):91–97.
    1. Alster TS, Konda S. Plasma Skin Resurfacing for Regeneration of Neck, Chest, and Hands: Investigation of a Novel Device. Dermatol Surg. 2007;33(11):1315–1321.
    1. Heinlin J, Isbary G, Stolz W, et al. Plasma applications in medicine with a special focus on dermatology. J Eur Acad Dermatol Venereol. 2011;25(1):1–11.
    1. Lin MG, Yang TL, Chiang CT, et al. Evaluation of dermal thermal damage by multiphoton autofluorescence and second-harmonic-generation microscopy. J Biomed Opt. 2006;11(6):064006.
    1. Foster KW, Moy RL, Fincher EF. Advances in plasma skin regeneration. J Cosmet Dermatol. 2008;7(3):169–179.
    1. Bogle MA, Arndt KA, Dover JS. Evaluation of plasma skin regeneration technology in low-energy full-facial rejuvenation. Arch Dermatol. 2007;143(2):168–174.
    1. Gonzalez MJ, Sturgill WH, Ross EV, Uebelhoer NS. Treatment of acne scars using the plasma skin regeneration (PSR) system. Lasers Surg Med. 2008;40(2):124–127.
    1. Kono T, Groff WF, Sakurai H, Yamaki T, Soejima K, Nozaki M. Treatment of traumatic scars using plasma skin regeneration (PSR) system. Lasers Surg Med. 2009;41(2):128–130.
    1. Higashimori T, Kono T, Sakurai H, Nakazawa H, Groff WF. Treatment of mesh skin grafted scars using a plasma skin regeneration system. Plast Surg Int. 2010;2010:874348.
    1. Fife D. Practical evaluation and management of atrophic acne scars: tips for the general dermatologist. J Clin Aesthet Dermatol. 2011;4(8):50–57.
    1. Fabbrocini G, Fardella N, Monfrecola A, Proietti I, Innocenzi D. Acne scarring treatment using skin needling. Clin Exp Dermatol. 2009;34(8):874–879.
    1. Camirand A, Doucet J. Needle dermabrasion. Aesthetic Plast Surg. 1997;21(1):48–51.
    1. Doddaballapur S. Microneedling with dermaroller. J Cutan Aesthet Surg. 2009;2(2):110–111.
    1. Fernandes D. Minimally invasive percutaneous collagen induction. Oral Maxillofac Surg Clin North Am. 2005;17(1):51–63.
    1. Majid I. Microneedling therapy in atrophic facial scars: an objective assessment. J Cutan Aesthet Surg. 2009;2(1):26–30.
    1. Fabbrocini G, De Vita V, Di Costanzo L, et al. Skin needling in the treatment of the aging neck. Skinmed. 2011;9(6):347–351.
    1. Park KY, Kim HK, Kim SE, Kim BJ, Kim MN. Treatment of striae distensae using needling therapy: a pilot study. Dermatol Surg. 2012;38(11):1823–1828.
    1. Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: An emerging transdermal drug delivery system. J Pharm Pharmacol. 2012;64(1):11–29.
    1. Kirkland EB, Gladstone HB, Hantash BM. What’s new in skin resurfacing and rejuvenation? G Ital Dermatol Venereol. 2010;145(5):583–596.
    1. Grimes PE. Microdermabrasion. Dermatol Surg. 2005;31(9 Pt 2):1160–1165.
    1. Shpall R, Beddingfield FC, 3rd, Watson D, Lask GP. Microdermabrasion: a review. Facial Plast Surg. 2004;20(1):47–50.
    1. Tan MH, Spencer JM, Pires LM, Ajmeri J, Skover G. The evaluation of aluminum oxide crystal microdermabrasion for photodamage. Dermatol Surg. 2001;27(11):943–949.
    1. Ignon R, Nicolas EF, inventors, Edge Systems Corporation, assignee Microdermabrasion apparatus and method. United States patent US20130102978 A1. April252013
    1. Waldron SH, inventor, Altair Instruments, Inc., assignee Microdermabrasion device and method of treating the skin surface. United States patent US 6241739 B1. Jun 5, 2001.
    1. Karimipour DJ, Rittie L, Hammerberg C, et al. Molecular analysis of aggressive microdermabrasion in photoaged skin. Arch Dermatol. 2009;145(10):1114–1122.
    1. Kim HS, Lim SH, Song JY, et al. Skin barrier function recovery after diamond microdermabrasion. J Dermatol. 2009;36(10):529–533.
    1. Khalaj B, inventor, Khalaj Ben M., assignee Hydro-dermabrasion apparatus and method of use. United States patent US 20070239173 A1. Oct 11, 2007.
    1. Rosso L, inventor, L.I.C.A. S.R.L., assignee Device for making hydro-microabrasions on human tissue. United States patent US 6432114 B1. Aug 13, 2002.
    1. Waldron SH, Kent P, inventors, Altair Instruments, Inc., assignee Device for applying liquid skincare products in combination with vacuum and abrasion. United States patent US 8221437 B2. Jul 17, 2012.
    1. Burke KE. Photodamage of the skin: protection and reversal with topical antioxidants. J Cosmetic Dermatol. 2004;3(3):149–155.
    1. Freedman BM. Hydradermabrasion: an innovative modality for nonablative facial rejuvenation. J Cosmet Dermatol. 2008;7(4):275–280.
    1. Kraemer KH. Sunlight and skin cancer: Another link revealed. Proc Nat Acad Sci U S A. 1997;94(1):11–14.
    1. Travers JB, Spandau DF, Lewis DA, et al. Fibroblast senescence and squamous cell carcinoma: how wounding therapies could be protective. Dermatol Surg. 2013;39(7):967–973.
    1. Lewis DA, Travers JB, Somani A-K, Spandau DF. The IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer. Oncogene. 2010;29(10):1475–1485.
    1. Lewis DA, Travers JB, Spandau DF. A new paradigm for the role of aging in the development of skin cancer. J Invest Dermatol. 2009;129(3):787–791.
    1. Lewis D, Travers J, Spandau D. Aging-associated Non-melanoma Skin Cancer: A Role for the Dermis. In: Farage M, Miller K, Maibach H, editors. Textbook of Aging Skin. Berlin Heidelberg: Springer; 2010. pp. 587–599.
    1. Lewis DA, Travers JB, Machado C, Somani AK, Spandau DF. Reversing the aging stromal phenotype prevents carcinoma initiation. Aging (Albany NY) 2011;3(4):407–416.
    1. Spandau DF, Lewis DA, Somani AK, Travers JB. Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin. J Invest Dermatol. 2012;132(6):1591–1596.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren